Pharmacological profile of T-0632, a novel potent and selective CCK A receptor antagonist, in vitro

By Taniguchi H.   Yazaki N.   Endo T.   Nagasaki M.  

European Journal of Pharmacology, Vol. 304, Iss. 1, 1996-05 ,pp. : 147-154

Elsevier

Access to resources Recommend Favorite

In Vivo Pharmacological Characterisation of Bilastine, a Potent and Selective Histamine H 1 Receptor Antagonist

By Corcóstegui Reyes   Labeaga Luis   Innerárity Ana   Berisa Agustín   Orjales Aurelio  

Drugs in R&D, Vol. 7, Iss. 4, 2006-01 ,pp. : 219-231

Adis International

Access to resources Recommend Favorite

In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist

By Ozaki S.   Kawamoto H.   Itoh Y.   Miyaji M.   Azuma T.   Ichikawa D.   Nambu H.   Iguchi T.   Iwasawa Y.   Ohta H.  

European Journal of Pharmacology, Vol. 402, Iss. 1, 2000-08 ,pp. : 45-53

Elsevier

Access to resources Recommend Favorite

A water-soluble, stable dipeptide NK 1 receptor-selective neurokinin receptor antagonist with potent in vivo pharmacological effects: S18523

By Bonnet J.   Kucharczyk N.   Robineau P.   Lonchampt M.   Dacquet C.   Regoli D.   Fauchere J.-L.   Canet E.  

European Journal of Pharmacology, Vol. 310, Iss. 1, 1996-08 ,pp. : 37-46

Elsevier

Access to resources Recommend Favorite

The in vivo pharmacological profile of eletriptan (UK-116,044): a potent and novel 5-HT 1B/1D receptor agonist

By Gupta P.   Butler P.   Shepperson N.B.   McHarg A.  

European Journal of Pharmacology, Vol. 398, Iss. 1, 2000-06 ,pp. : 73-81

Elsevier

Access to resources Recommend Favorite